Colchicine and Leukopenia: Clinical Implications.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32417084.
- Also identified by DOI 10.1016/j.jpeds.2020.03.065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Colchicine is the mainstay of treatment for familial Mediterranean fever. We investigated the frequency of leukopenia in 213 patients with familial Mediterranean fever treated with standard doses of colchicine (0.5-2.0 mg/day). We found that 23 patients (10.8%) had reversible leukopenia, 3 moderate, and none severe and that their rate of infections was not increased.
Medical subject headings
- Colchicine
- Familial Mediterranean Fever
- Leukopenia
- Tubulin Modulators